Ind-Swift Laboratories Ltd. benchmarking: Perfomance to industry peers

Financial

	Ind-Swift Lab.	Bharat Parenterals	Sakar Healthcare
Operational Metrics
Pharmaceutical Sector
Total reactor capacity	700.0 kL	n/a	n/a
DMF Filingsby API	474.0 .	n/a	n/a
R&D as a % of Total Sales	2.9 %	0.31 %	n/a
Financials
5 yr Average ROE	9.6 %	12.73 %	9.28 %
5yr average Equity Multiplier	2.49	1.76	1.75
5yr Average Asset Turnover Ratio	0.67	0.86	0.5
5yr Avg Net Profit Margin	6.7 %	8.73 %	10.38 %
Price to Book	0.73	2.66	2.84
P/E	3.72	0.0	41.08
5yr Avg Cash Conversion Cycle	76.78 Days	122.06 Days	-14.29 Days
Inventory Days	126.74 Days	46.56 Days	46.75 Days
Days Receivable	95.44 Days	179.99 Days	51.16 Days
Days Payable	94.9 Days	95.97 Days	103.34 Days
5yr Average Interest Coverage Ratio	3.49	22.68	5.43
5yr Avg ROCE	12.63 %	16.02 %	10.08 %
5yr Avg Operating Profit Margin	19.31 %	11.16 %	24.06 %
5 yr average Debt to Equity	1.22	0.26	0.47
5yr CAGR Net Profit	n/a	-9.67 %	3.94 %
5yr Average Return on Assets	7.66 %	8.0 %	5.37 %
Shareholdings
Promoter Holding	40.94 %	67.19 %	52.86 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-1.06 %	-6.65 %	-14.68 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Ind-Swift Lab.	Bharat Parenterals	Sakar Healthcare
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Loan Licensing 0 Export 0 CDMO 0	Product Wise Break-Up Pharmaceutical 0 CDMO 0 Export 0 Loan Licensing 0 Others 100	Product Wise Break-Up Pharmaceutical 0 CDMO 22.0 Export 73.0 Loan Licensing 5.0
Location Wise Break-Up	Location Wise Break-Up India 27.72 Rest of the World 0 International 0 Domestic 0 Others 72.28	Location Wise Break-Up Rest of the World 76.17 India 23.83 Domestic 0 International 0	Location Wise Break-Up Rest of the World 0 India 0 Domestic 44.52 International 55.48
Operating Profit Break-Up	Operating Profit Break-Up India 18.87 Others 81.13	-	-
Asset Break-Up	Asset Break-Up India 67.55 Others 32.45	-	-